Global Clinical Next-Generation Sequencing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Clinical Next-Generation Sequencing market size will reach US$ million by 2031.

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

United States market for Clinical Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Clinical Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Clinical Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Clinical Next-Generation Sequencing players cover Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Clinical Next-Generation Sequencing Industry Forecast” looks at past sales and reviews total world Clinical Next-Generation Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Next-Generation Sequencing sales for 2025 through 2031. With Clinical Next-Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Next-Generation Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Clinical Next-Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Next-Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Next-Generation Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Next-Generation Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Next-Generation Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Next-Generation Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Targeted Sequencing
Exome Sequencing
Others

Segmentation by Application:
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen

Please note: The report will take approximately 2 business days to prepare and deliver. Show more